Literature DB >> 26994402

Effect of systemic bevacizumab in severe hereditary hemorrhagic telangiectasia associated with bleeding.

Narendranath Epperla1, Jonathan T Kapke2, Matthew Karafin3, Kenneth D Friedman1, Patrick Foy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26994402     DOI： 10.1002/ajh.24367

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  8 in total

1.  Bevacizumab for Refractory Gastrointestinal Bleeding in Rendu-Osler-Weber Disease.

Authors:  Carlos Bernardes; Sara Santos; Rafaela Loureiro; Verónica Borges; Gonçalo Ramos
Journal:  GE Port J Gastroenterol       Date:  2017-10-05

2.  The Impact on COVID-19 by Intravenous Bevacizumab Used for Hereditary Hemorrhagic Telangiectasia: A Case Report.

Authors:  Ryan Patrick Fanning; Sara Strout; Nicholas R Rowan; Clifford R Weiss; Panagis Galiatsatos
Journal:  J Med Cases       Date:  2022-06-02

3.  A lack of race and ethnicity data in the treatment of hereditary hemorrhagic telangiectasia: a systematic review of intravenous bevacizumab efficacy.

Authors:  Panagis Galiatsatos; Cheri Wilson; Jaime O'Brien; Anna J Gong; Dylan Angiolillo; James Johnson; Carlie Myers; Sara Strout; Stephen Mathai; Gina Robinson; Nicholas R Rowan; Clifford R Weiss
Journal:  Orphanet J Rare Dis       Date:  2022-06-13       Impact factor: 4.303

4.  Systemic bevacizumab for refractory bleeding and transfusion-dependent anemia in Heyde syndrome.

Authors:  Andrew B Song; Rahul Sakhuja; Nancy M Gracin; Ronald Weinger; Raj S Kasthuri; Hanny Al-Samkari
Journal:  Blood Adv       Date:  2021-10-12

5.  High-Output Heart Failure Contributing to Recurrent Epistaxis Kiesselbach Area Syndrome in a Patient With Hereditary Hemorrhagic Telangiectasia.

Authors:  Venugopal Brijmohan Bhattad; Jennifer N Bowman; Hemang B Panchal; Timir K Paul
Journal:  J Investig Med High Impact Case Rep       Date:  2017-02-01

Review 6.  Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective.

Authors:  Athena Kritharis; Hanny Al-Samkari; David J Kuter
Journal:  Haematologica       Date:  2018-05-24       Impact factor: 9.941

7.  Diagnostic yield of capsule endoscopy for small bowel arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis.

Authors:  Kevin Singh; Ayla Zubair; Andrew Prindle; Ahmed Jamal Nadeem; Gulam Khan
Journal:  Endosc Int Open       Date:  2019-01-30

8.  An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study.

Authors:  Hanny Al-Samkari; Raj S Kasthuri; Joseph G Parambil; Hasan A Albitar; Yahya A Almodallal; Carolina Vázquez; Marcelo M Serra; Sophie Dupuis-Girod; Craig B Wilsen; Justin P McWilliams; Evan H Fountain; James R Gossage; Clifford R Weiss; Muhammad A Latif; Assaf Issachar; Meir Mei-Zahav; Mary E Meek; Miles Conrad; Josanna Rodriguez-Lopez; David J Kuter; Vivek N Iyer
Journal:  Haematologica       Date:  2021-08-01       Impact factor: 9.941
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.